Furthermore, we emphasized the crucial role of the NAT10/SEPT9/HIF‐1α positive feedback loop in regulation of glycolysis addiction and provided compelling in vitro and in vivo evidence demonstrating that targeting mRNA ac4C modification could be a promising therapeutic strategy for GC treatment. The gene discussed is HIF1A; the disease is gastric cancer.